Organometallics
Article
palladium.75,76 The def2-TZVP basis set and effective core potential77
was utilized in single-point energy calculations. The polarizable
continuum model (PCM)78 self-consistent reaction field (SCRF)
was used to model solvent effects, with a solvent of DMF to be
consistent with the experimental system. Select species were optimized
inclusive of solvent effects. Solvent effects are included in single-point
energies at the gas-phase optimized geometries. An SCF convergence
criteria of 10−8 au was employed throughout.
7.5 Hz, Haryl), 6.73 (d, 2H, 3JHH = 1.5 Hz, Himi), 6.94 (dd, 4H, 3JHH
=
7.5 Hz, 3JHH = 8.1 Hz, Haryl), 7.07 (d, 2H, 3JHH = 1.5 Hz, Himi), 7.62 (d,
3
4H, JHH = 8.1 Hz, Haryl) ppm. 13C NMR (d6-DMSO): δ 36.3 (CH3),
58.5 (CH2), 122.0 (Cimi), 122.3 (Cimi), 123.6 (Caryl), 126.4 (Caryl),
127.7 (Caryl), 151.0 (Cq), 171.1 (Pd-C), 171.4 (CO) ppm. Anal.
Found: C, 53.69; H, 4.73; N, 15.55. Calcd for C24H24N6O2Pd: C,
53.89; H, 4.52; N, 15.71.
Pd(II) Complex cis-1. The methanol solution (from the trituration
step in the synthesis of trans-1 above) was evaporated to dryness, and
the residue was further recrystallized from methanol to give cis-1 as a
white powder. Yield: 0.018 g (12%). 1H NMR (d6-DMSO): δ 3.31 (s,
6H, CH3), 4.31 (d, 2H, 2JHH = 14.4 Hz, CH2), 5.26 (d, 2H, 2JHH = 14.4
Hz, CH2), 6.69 (t, 2H, 3JHH = 7.2 Hz, Haryl), 6.82 (dd, 4H, 3JHH = 7.2
Synthesis. Imidazolium Salt [I]Cl.39 A solution of 2-chloro-N-
phenylacetamide (0.843 g, 4.97 mmol) and 1-methylimidazole (0.40
mL, 4.97 mmol) in acetonitrile (70 mL) was heated at reflux (100 °C)
for 16 h. A white precipitate formed, which was collected and washed
with diethyl ether (3 × 5 mL) to afford a white powder. Yield: 1.06 g
(85%). 1H NMR (d6-DMSO): δ 3.91 (s, 3H, CH3), 5.27 (s, 2H, CH2),
7.07 (t, 1H, 3JHH = 6.9 Hz, Haryl), 7.32 (dd, 2H, 3JHH = 6.9 Hz, J = 8.4
Hz, Haryl), 7.63 (d, 2H, 3JHH = 8.4 Hz, Haryl), 7.73 (s, 1H, Himi), 7.77 (s,
1H, Himi), 9.19 (s, 1H, NCHN), 11.04 (s, 1H, NH). 13C NMR (d6-
DMSO): δ 35.9 (CH3), 51.2 (CH2), 119.2 (Caryl), 123.0 (Cimi), 123.7
(Caryl), 123.9 (Cimi), 128.9 (Caryl), 137.8 (NCN), 138.5 (Cq), 163.7
(CO). Anal. Found: C, 57.41; H, 5.55; N, 16.78. Calcd for
C12H14ClN3O: C, 57.26; H, 5.61; N, 16.69.
3
3
Hz, JHH = 7.8 Hz, Haryl), 6.98 (d, 4H, JHH = 7.8 Hz, Haryl), 7.32 (d,
3
3
2H, JHH = 1.8 Hz, Himi), 7.61 (d, 2H, JHH = 1.8 Hz, Himi) ppm. 13C
NMR (d6-DMSO): δ 36.1 (CH3), 57.8 (CH2), 120.6 (Caryl), 122.0
(Cimi), 122.2 (Cimi), 125.7 (2 × Caryl), 147.8 (Cq), 163.1 (Pd-C), 166.5
(CO) ppm. Anal. Found: C, 51.55; H, 5.82; N, 13.10. Calcd for
C24H24N6O2Pd·3CH3OH: C, 51.39; H, 5.75; N, 13.32.
Pd(II) Complex trans-2. This compound was prepared from [II]·Cl
(0.11 g, 0.36 mmol), K2CO3 (0.25 g, 1.78 mmol), and K2PdCl4 (0.058
g, 0.18 mmol) in anhydrous dimethylformamide (25 mL) using the
method described for 1 to give trans-2 as a cream-colored powder.
Imidazolium Salt [II]Cl. This compound was prepared from 1-
phenylimidazole (0.50 g, 3.47 mmol) and 2-chloro-N-phenylacetamide
(0.59 g, 3.47 mmol) using the method described for [I]Cl. The
1
2
Yield: 0.026 g (23%). H NMR (d6-DMSO): δ 4.36 (d, 2H, JHH
=
=
product was obtained as a white powder. Yield: 0.82 g (75%). H
14.1 Hz, CH2), 5.41 (d, 2H, 2JHH = 14.1 Hz, CH2), 6.65 (t, 2H, 3JHH
1
3
NMR (d6-DMSO): δ 5.37 (s, 2H, CH2), 7.08 (t, 1H, JHH = 7.5 Hz,
7.1 Hz, Haryl), 6.82 (dd, 4H, 3JHH = 7.1 Hz, 3JHH = 7.5 Hz, Haryl), 6.95
(d, 4H, 3JHH = 7.5 Hz, Haryl), 7.40 (s, 2H, Himi), 7.51 (t, 4H, 3JHH = 7.2
Hz, Haryl and Himi), 7.63 (dd, 4H, 3JHH = 7.2 Hz, 3JHH = 7.8 Hz, Haryl),
7.82 (d, 4H, 3JHH = 7.8 Hz, Haryl) ppm. 13C NMR (d6-DMSO): δ 58.3
(CH2), 120.2 (Cimi), 121.3 (Caryl), 122.4 (Cimi), 123.4 (Caryl), 125.6
(Caryl), 126.0 (Caryl), 127.9 (Caryl), 128.6 (Caryl), 137.7 (Cq), 149.8 (Cq),
167.2 (Pd-C), 169.1 (CO) ppm. Anal. Found: C, 60.11; H, 4.33; N,
12.39. Calcd for C34H28N6O2Pd·H2O: C, 60.31; H, 4.47; N, 12.41.
Ni(II) Complex 3. To a solution of [III]Cl2 (0.13 g, 0.301 mmol) in
anhydrous dimethylformamide (15 mL) were added K2CO3 (0.21 g,
1.50 mmol) and a solution of NiCl2 (0.039 g, 0.301 mmol) in
anhydrous dimethylformamide (10 mL). The resultant mixture was
heated at 110 °C for 16 h, and after it was cooled to room
temperature, the mixture was filtered and the solvent was removed
under reduced pressure. The residue was recrystallized from a mixture
of dichloromethane and diethyl ether to give 3 as a light brown
3
3
Haryl), 7.33 (dd, 2H, JHH = 7.5 Hz, JHH = 8.1 Hz, Haryl), 7.60−7.65
3
(m, 5H, Haryl), 7.81 (d, 2H, JHH = 8.1 Hz, Haryl), 8.07 (s, 1H, Himi),
8.38 (s, 1H, Himi), 10.01 (s, 1H, NCHN), 11.15 (s, 1H, NH). 13C
NMR (d6-DMSO): δ 51.6 (CH2), 119.1 (Caryl), 120.7 (Cimi), 122.0
(Caryl), 123.7 (Caryl), 125.0 (Cimi), 128.8 (Caryl), 129.9 (Caryl), 130.5
(Caryl), 134.6 (Cq), 136.6 (NCN), 138.6 (Cq), 163.5 (CO). Anal.
Found: C, 65.00; H, 5.21; N, 13.45. Calcd for C17H16ClN3O: C, 65.07;
H, 5.14; N, 13.39.
Imidazolium Salt [III]Cl2. This compound was prepared from N,N′-
bis(chloroacetyl)1,2-phenylenediamine (0.6 g, 2.3 mmol) and 1-
methylimidazole (0.366 mL, 4.6 mmol) using the method described
for [I]Cl. The crude product was recrystallized from boiling ethanol to
1
give [III]Cl2 as a pale purple powder. Yield: 0.639 g (65%). H NMR
(d6-DMSO): δ 3.91 (s, 6H, CH3), 5.49 (s, 4H, CH2), 7.15−7.18 (m,
2H, Haryl), 7.58−7.62 (m, 2H, Haryl), 7.73 (s, 2H, Himi), 7.90 (s, 2H,
Himi), 9.35 (s, 2H, NCHN), 10.75 (s, 2H, NH). 13C NMR (d6-
DMSO): δ 35.9 (CH3), 51.5 (CH2), 123.0 (Cimi), 123.8 (Cimi), 124.7
(Caryl), 125.2 (Caryl), 129.8 (Cq), 137.8 (NCN), 164.3 (CO). Anal.
Found: C, 49.09; H, 5.19; N, 19.00. Calcd for C18H22Cl2N6O2·H2O:
C, 48.77; H, 5.46; N, 18.96.
1
powder. Yield: 0.027 g (21%). H NMR (d6-DMSO): δ 3.18 (s, 6H,
CH3), 4.66 (d, 2H, 2JHH = 17.1 Hz, CH2), 5.13 (d, 2H, 2JHH = 17.1 Hz,
CH2), 6.63−6.66 (m, 2H, Haryl), 7.32 (d, 2H, 3JHH = 1.8 Hz, Himi), 7.42
(d, 2H, 3JHH = 1.8 Hz, Himi), 8.30−8.33 (m, 2H, Haryl) ppm. 13C NMR
(d6-DMSO): δ 36.1 (CH3), 54.5 (CH2), 119.9 (Caryl), 121.3 (Cimi),
121.6 (Caryl), 123.7 (Cimi), 143.4 (Cq), 162.7 (Ni-C), 166.4 (CO)
ppm. Anal. Found: C, 49.57; H, 4.32; N, 18.75. Calcd for
C18H18N6O2Ni·0.5CH2Cl2: C, 49.21; H, 4.24; N, 18.61. The reported
elemental analysis results are provided to illustrate the best values
obtained to date. Copies of the NMR spectra (1H and 13C) are
provided in the Supporting Information (Figure S2) as additional
evidence of purity.
Imidazolium Salt [IV]Cl2. This compound was prepared from 1-
phenylimidazole (0.55 g, 3.81 mmol) and N,N′-bis(chloroacetyl)1,2-
phenylenediamine (0.50 g, 1.91 mmol) using the method described for
[III]Cl2 to give [IV]Cl2 as a pale pink powder. Yield: 0.735 g (70%).
1H NMR (d6-DMSO): δ 5.57 (s, 4H, CH2), 7.18−7.21 (m, 2H, Haryl),
7.57−7.69 (m, 8H, Haryl), 7.81−7.83 (m, 4H, Haryl), 8.18 (s, 2H, Himi),
8.37 (s, 2H, Himi), 10.18 (s, 2H, NCHN), 10.81 (s, 2H, NH). 13C
NMR (d6-DMSO): δ 52.0 (CH2), 120.6 (Cimi), 122.0 (Caryl), 124.8
(Cimi, Cq), 125.5 (Caryl), 129.9 (2 × Caryl), 130.5 (Caryl), 134.7 (Cq),
136.8 (NCN), 164.0 (CO). Anal. Found: C, 57.24; H, 5.43; N,
14.04. Calcd for C28H26Cl2N6O2·2H2O: C, 57.44; H, 5.16; N, 14.35.
Pd(II) Complex trans-1. To a solution of [I]Cl (0.15 g, 0.59 mmol)
in anhydrous dimethylformamide (15 mL) were added K2CO3 (0.41 g,
2.96 mmol) and a solution of K2PdCl4 (0.097 g, 0.30 mmol) in
anhydrous dimethylformamide (10 mL). The resultant mixture was
heated at 110 °C for 16 h, and after it was cooled to room
temperature, the mixture was filtered and the solvent removed under
reduced pressure. 1H NMR analysis of the crude product showed it to
be a mixture of cis and trans isomers of the title compound. The trans
isomer was isolated by adding methanol (10 mL), and after stirring for
15 min the insoluble solid was collected and washed with diethyl ether
Ni(II) Complex 4. This compound was prepared from a solution of
[IV]Cl2 (0.12 g, 0.21 mmol), K2CO3 (0.15 g, 1.06 mmol), and NiCl2
(0.028 g, 0.21 mmol) using the method described for 3, except the
reaction was conducted at 125 °C for 16 h. The crude product was
recrystallized from a mixture of dichloromethane and diethyl ether to
give 4 as a brown powder. Yield: 0.026 g (23%). 1H NMR (d6-
DMSO): δ 4.55 (dd, 2H, 2JHH = 17.1 Hz, CH2), 4.65 (dd, 2H, 2JHH
=
17.1 Hz, CH2), 6.69−6.73 (m, 2H, Haryl), 7.07 (d, 2H, 3JHH = 1.8 Hz,
3
3
Himi), 7.25 (d, 2H, JHH = 1.8 Hz, Himi), 7.34 (t, 2H, JHH = 7.5 Hz,
Haryl), 7.56 (dd, 4H, 3JHH = 7.5 Hz, 3JHH = 7.8 Hz, Haryl), 7.81 (d, 4H,
3JHH = 7.8 Hz, Haryl), 8.40−8.43 (m, 2H, Haryl) ppm. 13C NMR (d6-
DMSO): δ 54.2 (CH2), 120.1 (Caryl), 121.5 (Cimi), 121.6 (Caryl), 122.4
(Cimi), 124.3 (Caryl), 127.9 (Caryl), 128.8 (Caryl), 138.8 (Cq), 143.6 (Cq),
164.1 (Ni-C), 166.0 (CO) ppm. Anal. Found: C, 62.03; H, 4.28; N,
15.40. Calcd for C28H22N6O2Ni·0.5H2O: C, 62.02; H, 4.28; N, 15.50.
The reported elemental analysis results are provided to illustrate the
best values obtained to date. Copies of the NMR spectra (1H and 13C)
1
to give trans-1 as a cream-colored powder. Yield: 0.032 g (20%). H
NMR (MeOD + d6-DMSO): δ 3.63 (s, 6H, CH3), 4.23 (d, 2H, 2JHH
14.1 Hz, CH2), 5.42 (d, 2H, 2JHH = 14.1 Hz, CH2), 6.70 (t, 2H, 3JHH
=
=
1921
dx.doi.org/10.1021/om4000133 | Organometallics 2013, 32, 1913−1923